• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, July 24, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

German Research Foundation extends funding for basic research in the neurosciences

Bioengineer by Bioengineer
December 8, 2016
in Science News
Reading Time: 2 mins read
0
ADVERTISEMENT
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

The German Research Foundation (DFG) will be providing financial support to the Collaborative Research Center (CRC) 1080 on "Molecular and cellular mechanisms of neuronal homeostasis" for four more years. In addition to Johannes Gutenberg University Mainz (JGU), Goethe University Frankfurt as the CRC's speaker university, the Max Planck Institute for Brain Research, and the Mainz-based Institute of Molecular Biology (IMB) are participating in this research center. A total of some EUR 12 million is being made available in the new funding period that will commence on January 1, 2017.

CRC 1080 was established on January 1, 2013 with Johannes Gutenberg University Mainz acting as the speaker university. With the commencement of the new funding phase, the speaker role will be transferred to Frankfurt University which, as a member of the Rhine-Main Neuroscience Network (rmn²), is participating in the CRC with its own research projects. The future coordinator of the CRC, Professor Amparo Acker-Palmer, heads up the Frankfurt Institute for Cell Biology and Neurosciences and is also a fellow of the Gutenberg Research College (GRC) at JGU. Professor Heiko Luhmann, Director of the Institute of Physiology at the Mainz University Medical Center, will take up the post of deputy coordinator.

The purpose of the CRC on "Molecular and cellular mechanisms of neuronal homeostasis" is to study the molecular and cellular interactions that enable the brain to maintain a state of functional equilibrium, otherwise known as network homeostasis. New findings should contribute to understanding disease processes in the brain, thus providing insights in the development of innovative new therapies. This might even include the creation of new pharmaceutical agents that could be used to treat cerebral disorders in humans. Specifically, the researchers working at the CRC are investigating different classes of molecules, such as those involved in the control of cell-to-cell interactions and signaling processes.

"The extension of funding of the Collaborative Research Center 1080, which studies aspects that offer great potential benefits to society, owes much to our very productive and collaborative research endeavors," pointed out the Chief Scientific Officer of the Mainz University Medical Center, Professor Ulrich Förstermann.

###

Media Contact

Oliver Kreft
pr@unimedizin-mainz.de
49-613-117-7424
@uni_mainz_eng

Startseite der JGU

############

Story Source: Materials provided by Scienmag

Share12Tweet8Share2ShareShareShare2

Related Posts

Additive Manufacturing of Monolithic Gyroidal Solid Oxide Cells

July 20, 2025

Machine Learning Uncovers Sorghum’s Complex Mold Resistance

July 20, 2025

Pathology Multiplexing Revolutionizes Disease Mapping

July 20, 2025

Single-Cell Atlas Links Chemokines to Type 2 Diabetes

July 20, 2025
Please login to join discussion

POPULAR NEWS

  • Blind to the Burn

    Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.

    60 shares
    Share 24 Tweet 15
  • AI Achieves Breakthrough in Drug Discovery by Tackling the True Complexity of Aging

    70 shares
    Share 28 Tweet 18
  • USF Research Unveils AI Technology for Detecting Early PTSD Indicators in Youth Through Facial Analysis

    43 shares
    Share 17 Tweet 11
  • Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine

    46 shares
    Share 18 Tweet 12

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Additive Manufacturing of Monolithic Gyroidal Solid Oxide Cells

Machine Learning Uncovers Sorghum’s Complex Mold Resistance

Pathology Multiplexing Revolutionizes Disease Mapping

  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.